130 related articles for article (PubMed ID: 19213955)
41. Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model.
Pinkert S; Kespohl M; Kelm N; Kaya Z; Heuser A; Klingel K; Beling A
Viruses; 2021 Jun; 13(7):. PubMed ID: 34202636
[TBL] [Abstract][Full Text] [Related]
42. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.
Tschöpe C; Van Linthout S; Jäger S; Arndt R; Trippel T; Müller I; Elsanhoury A; Rutschow S; Anker SD; Schultheiss HP; Pauschinger M; Spillmann F; Pappritz K
ESC Heart Fail; 2020 Oct; 7(5):2838-2852. PubMed ID: 32662949
[TBL] [Abstract][Full Text] [Related]
43. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
44. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
45. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
46. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
47. Imatinib mesylate attenuates fibrosis in coxsackievirus b3-induced chronic myocarditis.
Leipner C; Grün K; Müller A; Buchdunger E; Borsi L; Kosmehl H; Berndt A; Janik T; Uecker A; Kiehntopf M; Böhmer FD
Cardiovasc Res; 2008 Jul; 79(1):118-26. PubMed ID: 18326555
[TBL] [Abstract][Full Text] [Related]
48. Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.
Kaese S; Larbig R; Rohrbeck M; Frommeyer G; Dechering D; Olligs J; Schönhofer-Merl S; Wessely R; Klingel K; Seebohm G; Eckardt L
PLoS One; 2017; 12(6):e0180029. PubMed ID: 28644868
[TBL] [Abstract][Full Text] [Related]
49. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
50. Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection.
Goetzke CC; Althof N; Neumaier HL; Heuser A; Kaya Z; Kespohl M; Klingel K; Beling A
Basic Res Cardiol; 2021 Feb; 116(1):7. PubMed ID: 33523326
[TBL] [Abstract][Full Text] [Related]
51. MG-132 attenuates cardiac deterioration of viral myocarditis via AMPK pathway.
Zhang XM; Li YC; Chen P; Ye S; Xie SH; Xia WJ; Yang JH
Biomed Pharmacother; 2020 Jun; 126():110091. PubMed ID: 32278272
[TBL] [Abstract][Full Text] [Related]
52. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
[TBL] [Abstract][Full Text] [Related]
53. Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-γ-Lyase/Hydrogen Sulfide Pathway.
Pan L; Zhang Y; Lu J; Geng Z; Jia L; Rong X; Wang Z; Zhao Q; Wu R; Chu M; Zhang C
J Cardiovasc Transl Res; 2015 Dec; 8(9):536-44. PubMed ID: 26525047
[TBL] [Abstract][Full Text] [Related]
54. Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity.
Antoniak S; Boltzen U; Riad A; Kallwellis-Opara A; Rohde M; Dörner A; Tschöpe C; Noutsias M; Pauschinger M; Schultheiss HP; Rauch U
J Mol Cell Cardiol; 2008 Jul; 45(1):118-26. PubMed ID: 18495150
[TBL] [Abstract][Full Text] [Related]
55. Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance.
Jin H; Guo X
Virol J; 2016 Oct; 13(1):168. PubMed ID: 27724948
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.
Zhu H; Lou C; Liu P
Virol J; 2015 Nov; 12():189. PubMed ID: 26578236
[TBL] [Abstract][Full Text] [Related]
57. Liver X receptor activation enhances CVB3 viral replication during myocarditis by stimulating lipogenesis.
Papageorgiou AP; Heggermont W; Rienks M; Carai P; Langouche L; Verhesen W; De Boer RA; Heymans S
Cardiovasc Res; 2015 Jul; 107(1):78-88. PubMed ID: 25998987
[TBL] [Abstract][Full Text] [Related]
58. Acute effects of an endothelin-1 receptor antagonist bosentan at different stages of heart failure in conscious dogs.
Choussat R; Hittinger L; Barbe F; Maistre G; Carayon A; Crozatier B; Su J
Cardiovasc Res; 1998 Sep; 39(3):580-8. PubMed ID: 9861300
[TBL] [Abstract][Full Text] [Related]
59. Coxsackievirus B3 induces viral myocarditis by upregulating toll-like receptor 4 expression.
Zhao Z; Cai TZ; Lu Y; Liu WJ; Cheng ML; Ji YQ
Biochemistry (Mosc); 2015 Apr; 80(4):455-62. PubMed ID: 25869363
[TBL] [Abstract][Full Text] [Related]
60. Low-dose N omega-nitro-L-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3.
Mikami S; Kawashima S; Kanazawa K; Hirata K; Hotta H; Hayashi Y; Itoh H; Yokoyama M
Circ Res; 1997 Oct; 81(4):504-11. PubMed ID: 9314831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
